Skip to main content
. 2023 Oct 24;2023(10):CD014722. doi: 10.1002/14651858.CD014722.pub2

ChiCTR2000039133.

Study name Randomized controlled trial of Enhancing Contact Model on reducing stigma of mental illness in family caregivers of persons with schizophrenia in rural China
Methods Study design: RCT
Country: China
Participants Family caregivers of persons with schizophrenia
Inclusion criteria: 
For family caregivers:
a. being the father or mother of a person with schizophrenia identified in 2015;
b. aged 38‐75 years;
c. living together with and caring for the patient;
d. not participants in our prior PFI studies;
e. able to provide written informed consent.
For person with schizophrenia:
a. identified in the 2015 survey;
b. aged ≥ 18 years;
c. not participants in our prior PFI studies.
Exclusion criteria:
For the family caregivers:
a. likely to engage in a risk behaviour (e.g. suicide or violence) imminently;
b. identified by a trained health professional as unsuitable to join the study (e.g. with mental illness).
Stated purpose: to test the short (post‐ intervention) and long‐term (9‐month follow‐up) effectiveness of a newly developed Enhancing Contact Model (ECM) Intervention for reducing self‐stigma in family caregivers of persons with schizophrenia, and to examine whether ECM is more effective in reducing self‐stigma than psychoeducational family intervention (PFI)
Interventions Intervention:
1. Enhancing Contact Model Programme Group
2. Psychoeducational Family Intervention Programme Group
Control:
Control group (not specified)
Outcomes Participants' outcomes of interest for this review
  1. Mental health symptoms/distress/PTSD (caregivers' burden)

  2. Quality of life


Economic outcomes
Nil
Time points: baseline, post‐intervention (specific time if provided)
Starting date From 1 September 2018 to 28 February 2021
Contact information Ran Maosheng, msran@hku.hk
Notes Source of funding: Research Grants Council, University Grants Committee, General Research Fund
Prospective trial registration number: ChiCTR2000039133